These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27876626)

  • 1. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition.
    Canna SW; Girard C; Malle L; de Jesus A; Romberg N; Kelsen J; Surrey LF; Russo P; Sleight A; Schiffrin E; Gabay C; Goldbach-Mansky R; Behrens EM
    J Allergy Clin Immunol; 2017 May; 139(5):1698-1701. PubMed ID: 27876626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoinflammation: NLRC4 mutation causes rare autoinflammatory disease.
    Bernard NJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):635. PubMed ID: 25266450
    [No Abstract]   [Full Text] [Related]  

  • 3. NLRC4 gets out of control.
    Khameneh HJ; Mortellaro A
    Nat Genet; 2014 Oct; 46(10):1048-9. PubMed ID: 25257084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.
    Canna SW; de Jesus AA; Gouni S; Brooks SR; Marrero B; Liu Y; DiMattia MA; Zaal KJ; Sanchez GA; Kim H; Chapelle D; Plass N; Huang Y; Villarino AV; Biancotto A; Fleisher TA; Duncan JA; O'Shea JJ; Benseler S; Grom A; Deng Z; Laxer RM; Goldbach-Mansky R
    Nat Genet; 2014 Oct; 46(10):1140-6. PubMed ID: 25217959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Mutation in the NBD Domain of
    Wang L; Wen W; Deng M; Li Y; Sun G; Zhao X; Tang X; Mao H
    Front Immunol; 2021; 12():674808. PubMed ID: 34248956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome.
    Weiss ES; Girard-Guyonvarc'h C; Holzinger D; de Jesus AA; Tariq Z; Picarsic J; Schiffrin EJ; Foell D; Grom AA; Ammann S; Ehl S; Hoshino T; Goldbach-Mansky R; Gabay C; Canna SW
    Blood; 2018 Mar; 131(13):1442-1455. PubMed ID: 29326099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoinflammation with Infantile Enterocolitis Associated with Recurrent Perianal Abscesses.
    Siahanidou T; Nikaina E; Kontogiorgou C; Tzanoudaki M; Stefanaki K; Skiathitou AV; Petropoulou T; Kanariou M
    J Clin Immunol; 2019 Apr; 39(3):237-240. PubMed ID: 30864118
    [No Abstract]   [Full Text] [Related]  

  • 8. The autoinflammation-associated NLRC4
    Eeckhout E; Asaoka T; Van Gorp H; Demon D; Girard-Guyonvarc'h C; Andries V; Vereecke L; Gabay C; Lamkanfi M; van Loo G; Wullaert A
    Front Immunol; 2023; 14():1272639. PubMed ID: 38090573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation.
    Romberg N; Al Moussawi K; Nelson-Williams C; Stiegler AL; Loring E; Choi M; Overton J; Meffre E; Khokha MK; Huttner AJ; West B; Podoltsev NA; Boggon TJ; Kazmierczak BI; Lifton RP
    Nat Genet; 2014 Oct; 46(10):1135-1139. PubMed ID: 25217960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome.
    Barsalou J; Blincoe A; Fernandez I; Dal-Soglio D; Marchitto L; Selleri S; Haddad E; Benyoucef A; Touzot F
    Front Immunol; 2018; 9():2162. PubMed ID: 30319625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC4 gain-of-function variant is identified in a patient with systemic lupus erythematosus.
    Wang Q; Ye X; Zheng W; Jin T; Zhou Y; Hu X; Zhou Q; Yu X
    Clin Immunol; 2023 Oct; 255():109731. PubMed ID: 37567492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cases of autoinflammatory disease with novel NLRC4 mutations, and the first mutation reported in the CARD domain of NLRC4 associated with autoinflammatory infantile enterocolitis (AIFEC).
    Asna Ashari K; Parvaneh N; Mirnia K; Ayati M; Saeedi M; Salehzadeh F; Shahrooei M; Sangsari R; Rohani P; Ziaee V
    Pediatr Rheumatol Online J; 2024 Oct; 22(1):90. PubMed ID: 39425177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoinflammatory mutation in NLRC4 reveals a leucine-rich repeat (LRR)-LRR oligomerization interface.
    Moghaddas F; Zeng P; Zhang Y; Schützle H; Brenner S; Hofmann SR; Berner R; Zhao Y; Lu B; Chen X; Zhang L; Cheng S; Winkler S; Lehmberg K; Canna SW; Czabotar PE; Wicks IP; De Nardo D; Hedrich CM; Zeng H; Masters SL
    J Allergy Clin Immunol; 2018 Dec; 142(6):1956-1967.e6. PubMed ID: 29778503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRC4 inflammasomopathies.
    Romberg N; Vogel TP; Canna SW
    Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):398-404. PubMed ID: 28957823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis.
    Soares JL; Oliveira EM; Pontillo A
    Mult Scler Relat Disord; 2019 Apr; 29():26-34. PubMed ID: 30658261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites.
    Liang J; Alfano DN; Squires JE; Riley MM; Parks WT; Kofler J; El-Gharbawy A; Madan-Kheterpal S; Acquaro R; Picarsic J
    Pediatr Dev Pathol; 2017; 20(6):498-505. PubMed ID: 28403691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of NLRP3, NLRC4 and NLRP6 inflammasomes in patients with primary immune thrombocytopenia.
    Lv Y; Ruan G; Liu Y; Cui D; Zhao Y; Yan C; Lv M; Xu D; Mao Y; Cao J; Jin J; Xie J
    Thromb Res; 2019 Apr; 176():101-103. PubMed ID: 30802690
    [No Abstract]   [Full Text] [Related]  

  • 18. An inherited mutation in NLRC4 causes autoinflammation in human and mice.
    Kitamura A; Sasaki Y; Abe T; Kano H; Yasutomo K
    J Exp Med; 2014 Nov; 211(12):2385-96. PubMed ID: 25385754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).
    Johansson Å; Eriksson N; Becker RC; Storey RF; Himmelmann A; Hagström E; Varenhorst C; Axelsson T; Barratt BJ; James SK; Katus HA; Steg PG; Syvänen AC; Wallentin L; Siegbahn A;
    Circ Cardiovasc Genet; 2015 Jun; 8(3):498-506. PubMed ID: 25747584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical update on inflammasomopathies.
    Sönmez HE; Özen S
    Int Immunol; 2017 Nov; 29(9):393-400. PubMed ID: 28387826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.